{"disease":{"id":"toothaches","name":"toothaches"},"drugs":{"marketed":[{"drug_id":"antipyrine","indication_name":"Toothaches","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ANTIPYRINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":10,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03472456","title":"Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}